The leading CEO forum for pharmaceutical producers, distributors and retailers in Russia

11 - 12 November 2020

Corinthia Saint-Petersburg Hotel

Oxana Monge, General Manager, Sanofi Eurasia
Oxana Monge

General Manager

Sanofi Eurasia

Niels Hessmann, Managing Director, Russia, Senior Representative, Russia and CIS, Bayer
Niels Hessmann

Managing Director, Russia, Senior Representative, Russia and CIS

Bayer

Ekaterina Pogodina, Managing Director, Russia & CIS, Johnson & Johnson
Ekaterina Pogodina

Managing Director, Russia & CIS

Johnson & Johnson

Matthias Wernicke, General Manager Russia and CIS, Merck
Matthias Wernicke

General Manager Russia and CIS

Merck

Oleg Dubianskij, Vice-President, Russia, GSK
Oleg Dubianskij

Vice-President, Russia

GSK

Inna Bakumenko, General Manager Russia and CIS, Abbott
Inna Bakumenko

General Manager Russia and CIS

Abbott

Marek Vasicek, General Manager, Russia, Bristol Myers Squibb
Marek Vasicek

General Manager, Russia

Bristol Myers Squibb

Erick Roche, General Manager, Teva
Erick Roche

General Manager

Teva

Irina Zaporozhets,  General Manager, Russia & CIS, Eli Lilly & Company
Irina Zaporozhets

General Manager, Russia & CIS

Eli Lilly & Company

Elena Kartasheva, President, Takeda
Elena Kartasheva

President

Takeda

Stephan Eder, Executive Vice President, Russia and CIS, STADA
Stephan Eder

Executive Vice President, Russia and CIS

STADA

Manlio Florenzano, General Manager, Sandoz
Manlio Florenzano

General Manager

Sandoz

Adlane Soudani, General Manager, Ipsen
Adlane Soudani

General Manager

Ipsen

Peter Rodionov, General Manager, Geropharm
Peter Rodionov

General Manager

Geropharm

Vladimir Khristenko, President, Nanolek
Vladimir Khristenko

President

Nanolek

Elena Litvinova, General Director, NovaMedica
Elena Litvinova

General Director

NovaMedica

Valentina Buchneva, Head of Region Eurasia, Bosnalijek
Valentina Buchneva

Head of Region Eurasia

Bosnalijek

Alexander Kuzin, Retail General Director, Pharmacy Chain 36.6
Alexander Kuzin

Retail General Director

Pharmacy Chain 36.6

Vadim Muzyayev, President, Protek
Vadim Muzyayev

President

Protek

Vladimir Nesterenko, General Director, Pharmacy Chain 36.6
Vladimir Nesterenko

General Director

Pharmacy Chain 36.6

Alexander Filippov, General Director, Rigla
Alexander Filippov

General Director

Rigla

Dmitry Pogrebinsky, General Director, Protek
Dmitry Pogrebinsky

General Director

Protek

Yury Krestinskiy, Chairman of the Expert Board, Institute of Public Healthcare Development
Yury Krestinskiy

Chairman of the Expert Board

Institute of Public Healthcare Development

Alexandr Sokolov, Директор по работе с ключевыми клиентами, Teva
Alexandr Sokolov

Директор по работе с ключевыми клиентами

Teva

Alexander Sotnik, Head of My Health project, Protek
Alexander Sotnik

Head of My Health project

Protek

Lilia Titova, Executive Director, The Union of Professional Pharmaceutical Organizations (SPFO)
Lilia Titova

Executive Director

The Union of Professional Pharmaceutical Organizations (SPFO)

Igor Bakhmetiev, Commercial Director, Russia and CIS, STADA
Igor Bakhmetiev

Commercial Director, Russia and CIS

STADA

Margarita Mustafina, Quality Director, Russia and Eurasia, Teva
Margarita Mustafina

Quality Director, Russia and Eurasia

Teva

Mariya Burchakova, Market Access and Public Affairs Director, Russia & CIS, Ipsen
Mariya Burchakova

Market Access and Public Affairs Director, Russia & CIS

Ipsen

Ilya Afanasov, Head of PMO & BD&L, Cluster Russia, Ukraine & CIS, Consumer Health, Bayer
Ilya Afanasov

Head of PMO & BD&L, Cluster Russia, Ukraine & CIS, Consumer Health

Bayer

Vera Emelyanova, Medical Director, Ipsen
Vera Emelyanova

Medical Director

Ipsen

Elena Nevolina, Executive Director, National Pharmaceutical Chamber
Elena Nevolina

Executive Director

National Pharmaceutical Chamber

Pharma versus coronavirus: interviews with General Directors 

General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19. 

The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products. 

The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation. 

 

READ OUR PHRAMACEUTICAL BLOG>>

Key topics at the Russian Pharmaceutical Forum 2020:

  • Seeking solutions to the critical healthcare problems in Russia
  • Analysis of the key regulatory changes affecting pharmaceutical industry
  • COVID-19 pandemic: the response of the Russian pharmaceutical market
  • Drug pricing methodologies aimed at stimulating innovation
  • Drug labelling - success stories and implementation case studies
  • Public procurement optimisation and the formation of the Essential and Vital Drug List
  • How to ensure access to innovative treatments on the Russian market?
  • International drug R&D innovation implementation practices
  • Common Eurasian Economic Union drug market - next steps in regulatory harmonisation
  • Evolution in the producer - distributor - retailer dynamics
  • Sales trends, purchasing power and consumer demand forecasts
  • Developing local active pharmaceutical substance production market
  • Medicine of the future: genomics, biotechnologies, personalised medicine

  • Digital healthcare: telemedicine today and in the future
  • IT trends: mobile technologies, the Internet of Things, blockchain in pharma
  • Big data and artificial intelligence in drug development and diagnostics
  • Data-centric marketing and data analytics for strategic planning
  • Smart technologies and innovation in drug manufacturing
  • New business models and online retail: consumer market transformation
  • Skill crisis: how to secure highly competent staff for your business?
  • Analytics, opportunities to share best practice, success stories from top pharma leaders

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

Amongst 600+ PARTICIPANTS:

Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare

Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals

Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences

WHY TO ATTEND THE RUSSIAN PHARMACEUTICAL FORUM?

russianpharma 018

The highest profile 100+ executive-level speakers and 600+ attendees 

russianpharma 150

Unrivalled networking opportunities